Global Gene-based Therapy Medicinal Supply, Demand and Key Producers, 2023-2029

Global Gene-based Therapy Medicinal Supply, Demand and Key Producers, 2023-2029

The global Gene-based Therapy Medicinal market size is expected to reach $ 44180 million by 2029, rising at a market growth of 24.9% CAGR during the forecast period (2023-2029).

The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

This report studies the global Gene-based Therapy Medicinal demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene-based Therapy Medicinal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene-based Therapy Medicinal that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Gene-based Therapy Medicinal total market, 2018-2029, (USD Million)

Global Gene-based Therapy Medicinal total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Gene-based Therapy Medicinal total market, key domestic companies and share, (USD Million)

Global Gene-based Therapy Medicinal revenue by player and market share 2018-2023, (USD Million)

Global Gene-based Therapy Medicinal total market by Type, CAGR, 2018-2029, (USD Million)

Global Gene-based Therapy Medicinal total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Gene-based Therapy Medicinal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene-based Therapy Medicinal market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gene-based Therapy Medicinal Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gene-based Therapy Medicinal Market, Segmentation by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Global Gene-based Therapy Medicinal Market, Segmentation by Application
Neurological Diseases
Cancer
Other

Companies Profiled:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Key Questions Answered

1. How big is the global Gene-based Therapy Medicinal market?

2. What is the demand of the global Gene-based Therapy Medicinal market?

3. What is the year over year growth of the global Gene-based Therapy Medicinal market?

4. What is the total value of the global Gene-based Therapy Medicinal market?

5. Who are the major players in the global Gene-based Therapy Medicinal market?